BOBBY FRANKLIN

Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including implementation of the U.S. AI Action Plan; investment in critical technology areas; federal research funding and grant administration policies affecting startups, universities, and technology commercialization, including OMB proposed Regulation for Federal Financial Assistance.

Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines

Issues related to procurement through the Department of Defense; issues related to private capital and procurement as it relates to the FY2027 National Defense Authorization Act (NDAA).

Energy tax credits included in H.R.l, The One Big Beautiful Bill Act; H.R. 4776, the Standardizing Permitting and Expediting Economic Development Act (SPEED Act). Energy permitting reform; ARPA-E.

Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas; OPT and STEM OPT Extention.

SBIR/STTR reauthorization; the SBIC accrual debenture license.

S. 445, The Carried Interest Fairness Act of 2025; H.R. 1091, The Carried Interest Fairness Act; S. 695, The Small Business Investment Act of 2025; H.R. 1199, The Small Business Investment Act of 2025; S. 866, The American Innovation and Jobs Act of 2025; H.R. 1990, The American Innovation and R&D Competitiveness Act of 2025; Implementation of H.R. 1, The One Big Beautiful Bill Act of 2025; Public Law No. 115-97 (The Tax Cuts and Jobs Act); Energy Tax Credits included in Public Law No. 117-169 (The Inflation Reduction Act); Qualified Small Business Stock (QSBS) under Internal Revenue Code Section 1202; digital asset taxation.

Monitor updated export control regulations.

Intellectual property issues that impact startups.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; streamlining the FDA approval process, implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; federal research funding, Advanced Research Project Agency- Health; AI in healthcare; The Ensuring Patient Access to Critical Breakthrough Products Act; RAPID Coverage Pathway; ARPA-H.

Issues related to streamlining procurement through the Department of Defense; issues related to private capital and procurement as it relates to the FY2026 National Defense Authorization Act (NDAA).

Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392)

Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas.

Implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684; Energy tax credits included in H.R.1, The One Big Beautiful Bill Act; Energy permitting reform; ARPA-E.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; streamlining the FDA approval process, implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; federal research funding, Advanced Research Project Agency- Health.

Intellectual property issues that impact startups.

Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including development of a U.S. AI Action Plan; CREATE AI Act H.R.2385; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Implementation of Infrastructure Investment and Jobs Act H.R.3684; Implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

SBIR/STTR reauthorization; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; the SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346. Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines

Monitor updated export control regulations.

Monitor updated export control regulations.

Capital gains tax policy, including carried interest; Qualified Small Business Stock; Stock options; Partnership tax policy; R&D credit expensing; American Innovation and R&D Competitiveness Act H.R.1990; Tax Cuts and Jobs Act H.R.1; Climate and energy tax issues, including production and investment tax credits and Section 45Q; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Small Business Jobs Act H.R.3937; Build It In America Act H.R.3938.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Safeguarding Rule proposal, Documentation of Registered Investment Adviser Compliance Reviews proposal, issues around Regulation D, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues; JOBS Act 4.0; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; foreign outbound investment restrictions; FinCEN proposed rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers.

Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas.

Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines.

Implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684; Energy tax credits; Energy permitting reform; ARPA-E.

Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including development of a U.S. AI Action Plan; CREATE AI Act H.R.2385; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Implementation of Infrastructure Investment and Jobs Act H.R.3684; Implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

SBIR/STTR reauthorization; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

SBIR/STTR programs; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Implementation of Infrastructure Investment and Jobs Act H.R.3684.

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

Creation of a Startup Visa; International Entrepreneur Rule.

Monitor updated export control regulations.

Intellectual property issues that impact startups; NIST Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

Climate and sustainability policy issues, including energy tax issues; ARPA-E; implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Capital gains tax policy, including carried interest; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; American Innovation & Jobs Act S.866; American Innovation Act H.R.368; Climate and energy tax issues, including production and investment tax credits and Section 45Q; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Tax Cuts for Working Families Act H.R.3936; Small Business Jobs Act H.R.3937; Build It in America Act H.R.3938.

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346.

Implementation of Infrastructure Investment and Jobs Act H.R.3684.

Antitrust and competition policy impacting startups; FTC proposed rulemaking regarding Hart-Scott-Rodino premerger notification program; FTC-DOJ Draft Merger Guidelines.

Intellectual property issues that impact startups; NIST Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

Creation of a Startup Visa; International Entrepreneur Rule.

SBIR/STTR programs; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Safeguarding Rule proposal, Documentation of Registered Investment Adviser Compliance Reviews proposal, issues around Regulation D, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Keep Innovation in America Act H.R.1414; JOBS Act 4.0; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; foreign outbound investment restrictions; FinCEN proposed rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Intellectual property issues that impact startups; NIST Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

Capital gains tax policy, including carried interest; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; American Innovation & Jobs Act S.866; American Innovation Act H.R.368; Climate and energy tax issues, including production and investment tax credits and Section 45Q; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Tax Cuts for Working Families Act H.R.3936; Small Business Jobs Act H.R.3937; Build It in America Act H.R.3938.

Creation of a Startup Visa; International Entrepreneur Rule.

Antitrust and competition policy impacting startups; FTC proposed rulemaking regarding Hart-Scott-Rodino premerger notification program; FTC-DOJ Draft Merger Guidelines.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Safeguarding Rule proposal, Documentation of Registered Investment Adviser Compliance Reviews proposal, issues around Regulation D, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Keep Innovation in America Act H.R.1414; JOBS Act 4.0; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; foreign outbound investment restrictions; FinCEN proposed rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

SBIR/STTR programs; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Monitor updated export control regulations.

Monitor updated export control regulations.

Capital gains tax policy, including carried interest; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; American Innovation & Jobs Act S.866; American Innovation Act H.R.368; Climate and energy tax issues, including production and investment tax credits and Section 45Q; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Tax Cuts for Working Families Act H.R.3936; Small Business Jobs Act H.R.3937; Build It in America Act H.R.3938.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346.

Creation of a Startup Visa; International Entrepreneur Rule.

Intellectual property issues that impact startups; NIST Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

SBIR/STTR programs; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684.

Antitrust and competition policy impacting startups; FTC proposed rulemaking regarding Hart-Scott-Rodino premerger notification program; FTC-DOJ Draft Merger Guidelines.

Capital gains tax policy, including carried interest; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; American Innovation & Jobs Act S.866; American Innovation Act H.R.368; Climate and energy tax issues, including production and investment tax credits and Section 45Q; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Tax Cuts for Working Families Act H.R.3936; Small Business Jobs Act H.R.3937; Build It in America Act H.R.3938.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Safeguarding Rule proposal, Documentation of Registered Investment Adviser Compliance Reviews proposal, issues around Regulation D, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Keep Innovation in America Act H.R.1414; JOBS Act 4.0; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; foreign outbound investment restrictions.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Antitrust and competition policy impacting startups; FTC proposed rulemaking regarding Hart-Scott-Rodino premerger notification program; FTC-DOJ Draft Merger Guidelines.

Intellectual property issues that impact startups; NIST Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346.

Monitor updated export control regulations.

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Safeguarding Rule proposal, Documentation of Registered Investment Adviser Compliance Reviews proposal, issues around Regulation D, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Keep Innovation in America Act H.R.1414; JOBS Act 4.0; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; foreign outbound investment restrictions.

Intellectual property issues that impact startups.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Implementation of Infrastructure Investment and Jobs Act H.R.3684.

SBIR/STTR programs; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Let Immigrants Kickstart Employment Act H.R.4681; international entrepreneur rule.

Issues related to diversity and inclusion in the venture capital workforce; issues related to workforce development and implementation of Inflation Reduction Act (H.R.5376) Public Law No. 117-169, the Infrastructure Investment and Jobs Act H.R.3684, and the CHIPS and Science Act H.R.4346.

Implementation of Infrastructure Investment and Jobs Act H.R.3684.

Monitor updated export control regulations.

SBIR/STTR programs; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; creation of an SBIC accrual debenture license for critical technology investment funds; 7(a) affiliation rulemaking.

Intellectual property issues that impact startups.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Let Immigrants Kickstart Employment Act H.R.4681; international entrepreneur rule.

Capital gains tax policy, including carried interest; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; American Innovation & Jobs Act S.866; American Innovation Act H.R.368; Climate and energy tax issues, including production and investment tax credits and Section 45Q; Implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Tax Cuts for Working Families Act H.R.3936; Small Business Jobs Act H.R.3937; Build It in America Act H.R.3938.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684.

Antitrust and competition policy impacting startups; FTC proposed rulemaking regarding Hart-Scott-Rodino premerger notification program.

Let Immigrants Kickstart Employment Act H.R.4681; international entrepreneur rule.

Intellectual property issues that impact startups.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Safeguarding Rule proposal, Documentation of Registered Investment Adviser Compliance Reviews proposal, issues around Regulation D, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Keep Innovation in America Act H.R.1414; JOBS Act 4.0; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; foreign outbound investment restrictions.

Monitor updated export control regulations.

Basic research funding and technology commercialization issues; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; implementation of Infrastructure Investment and Jobs Act H.R.3684; implementation of CHIPS and Science Act H.R.4346 TIP Directorate and program appropriations.

Antitrust and competition policy impacting startups.

Implementation of Infrastructure Investment and Jobs Act H.R.3684.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; implementation issues around the Inflation Reduction Act (H.R.5376) Public Law No. 117-169 and the Infrastructure Investment and Jobs Act H.R.3684.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.1691; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; Advanced Research Project Agency- Health.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.

Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.

Intellectual property issues that impact startups.

Infrastructure Investment and Jobs Act H.R.3684.

SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.

Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.

Issues related to diversity and inclusion in the venture capital workforce.

Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.

Intellectual property issues that impact startups.

Infrastructure Investment and Jobs Act H.R.3684.

Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.

Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.

Intellectual property issues that impact startups.

SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.

Infrastructure Investment and Jobs Act H.R.3684.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.

SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.

Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.

Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.

Intellectual property issues that impact startups.

Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.

Issues related to diversity and inclusion in the venture capital workforce.

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.

SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.

Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.

Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.

Infrastructure Investment and Jobs Act H.R.3684.

SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759

Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197

Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act H.R.3448;

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R. 3684.

Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule

Issues related to diversity and inclusion in the venture capital workforce

Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.

Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R. 3684.

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Opportunity and Competition Act H.R.3826

Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.

Startup visa; international entrepreneur rule; STEM visas

SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.

Capital gains tax policy, including carried interest; Carried Interest Fairness Act HR 1068/S 1598; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S 1288

Intellectual property issues that impact startups;

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act HR 4043;

Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Volcker Rule; Revising the SEC definition of venture capital fund/DEAL Act; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act HR 3448;

SBIR/STTR programs;Next Generation Entrepreneurship Corps Act S 389/HR 1226;

Startup visa; international entrepreneur rule;STEM visas

Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA)

Endless Frontier Act; Basic research funding and technology commercialization issues; NSF for the Future Act

Climate and sustainability policy issues, including energy tax issues; ARPA-E;

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology;

Small capitalization company capital formation issues; Special Purpose Acquisition Companies; disclosure of material short positions; issues related to improving research coverage for small companies; Volcker Rule; Revising the SEC definition of venture capital fund/DEAL Act; Implementation of the Foreign Investment Risk Review Modernization Act; blockchain regulatory and policy issues including the Token Taxonomy Act, including FinCEN rule regarding convertible virtual currencies; beneficial ownership rules implementation; Helping Startups Continue to Grow Act

Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)

Issues related to the Tax Cuts and Jobs Act; Section 1061 regulations; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit; IGNITE American Innovation Act HR 7917; HEROES Act HR 6800; Tax bills to encourage American innovation and medical independence, HRs 7766, 7505, 7556; American Innovation and Jobs Act S. 4822

Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act

Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196

Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144 and FinCEN rule regarding convertible virtual currencies; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 8603; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Main Street Loan Program.

Cybersecurity; data privacy issues; Net Neutrality; fintech; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups

Issues related to the Tax Cuts ands Jobs Act; Section 1061 regulations; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit; IGNITE American Innovation Act HR 7917; HEROES Act HR 6800; Tax bills to encourage American innovation and medical independence, HRs 7766, 7505, 7556

Cybersecurity; data privacy issues; Net Neutrality; fintech; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups

Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196

Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)

Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; Comprehensive Immigration Reform; International Entrepreneur Rule

Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543

Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019; Endless Frontier Act S. 3832/ H.R. 6978

Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)

Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196

Issues related to the Tax Cuts ands Jobs Act; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit.

Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Request to temporarily waive notarization requirements for Form ID filings during COVID-19 crisis; Request to allow flexibility in custody rule during COVID-19 crisis; Main Street Loan Program.

Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019; Endless Frontier Act S. 3832/ H.R. 6978

Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups

Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule

Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019

Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act

Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Request to temporarily waive notarization requirements for Form ID filings during COVID-19 crisis; Request to allow flexibility in custody rule during COVID-19 crisis

Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543

Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule

Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196

Issues related to the Tax Cuts ands Jobs Act; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207

Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543

Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019

Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535

Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act

Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule

Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups

Issues related to the Tax Cuts ands Jobs Act; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues; Research & Development Tax Credit Expansion Act, S. 2207

Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act

Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy

Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs;

Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019

Issues related to the Tax Cuts ands Jobs Act; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues

Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations

Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking

Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule

Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations

Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs;

Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act

Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy

Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking

H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382 including H.R. 6756 the American Innovation Act, medical device tax repeal, tax extenders, energy innovation tax issues, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444, Retirement, Savings, and Other Tax Relief Act of 2018, H.R. 88.

Small company capital formation issues, capital markets reform to encourage more US IPOs, JOBS and Investor Confidence Act, H.R. 5054 the Small Company Disclosure Simplification Act, H.R. 5756 to require the SEC to adjust resubmission thresholds for shareholder proposals, H.R. 5970 Modernizing Disclosures for Investors Act, H.R. 6130 Helping Startups Continue to Grow Act, H.R. 6139 Improving Investment Research for Small and Emerging Issuers Act, Proposals to expand the definition of smaller reporting company (SRC),Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker Rule, Registered Investment Advisor rules, the Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 6177/S. 3575, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, Corporate Governance Reform and Transparency Act H.R. 4015, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act S. 2098/H.R. 4311, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, cryptocurrency regulation, and House Innovation Initiative.

Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390/H.R. 5340.

Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.

Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.

Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390/H.R. 5340.

Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382 including H.R. 6756 the American Innovation Act, medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.

Small company capital formation issues, capital markets reform to encourage more US IPOs, JOBS and Investor Confidence Act, H.R. 5054 the Small Company Disclosure Simplification Act, H.R. 5756 to require the SEC to adjust resubmission thresholds for shareholder proposals, H.R. 5970 Modernizing Disclosures for Investors Act, H.R. 6130 Helping Startups Continue to Grow Act, H.R. 6139 Improving Investment Research for Small and Emerging Issuers Act, Proposals to expand the definition of smaller reporting company (SRC),Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker Rule, Registered Investment Advisor rules, the Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 6177, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, Corporate Governance Reform and Transparency Act H.R. 4015, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act S. 2098/H.R. 4311, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, cryptocurrency regulation, and House Innovation Initiative.

Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.

Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.

Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.

Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Basic science research funding and tech transfer issues, Innovators to Entrepreneurs Act H.R. 5086.

Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.

Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.

Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.

Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.

Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.

Basic science research funding and tech transfer issues, Innovators to Entrepreneurs Act H.R. 5086.

Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.

Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.

Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.

Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390.

Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.

Small company capital formation issues, capital markets reform to encourage more US IPOs; Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, H.R. 4015 Corporate Governance Reform and Transparency Act, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, and House Innovation Initiative.

Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Tax reform, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options.

Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.

Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.

Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy; Medical Device User Fee Act reauthorization; Prescription Drug User Fee Act reauthorization.

Various patent litigation reforms that impact investment in the start-up ecosystem.

Drug pricing, the Promises for Antibiotics and Therapeutics for Health Act, proposals to create limited use pathways for certain drugs, CMS reimbursement policy, Medical Device User Fee Act reauthorization, Prescription Drug User Fee Act reauthorization.

Cybersecurity, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act, augmented reality, Fintech, FirstNet.

Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Small company capital formation issues, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.

Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; and Comprehensive Immigration Reform.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202 startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform, R&D credit, stock options.

Small company capital formation issues, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.

Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act, augmented reality.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform, R&D credit.

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

21st Century Cures Initiative, drug pricing issues, the Promises for Antibiotics and Therapeutics for Health Act (S.185), proposals to create limited use pathways for certain drugs, CMS reimbursement.

Various patent litigation reforms that impact investment in the start-up ecosystem, including H.R. 9, S.1137, the TROL Act, and STRONG Patents Act.

Basic science research funding and tech transfer issues.

Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration. EB-5 Visa, and Comprehensive Immigration Reform.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.

Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.

Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act, STRONG Patents Act.

Various patent litigation reforms that impact investment in the start-up ecosystem, including H.R. 9, S.1137, the TROL Act, and STRONG Patents Act.

Basic science research funding and tech transfer issues.

Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; and Comprehensive Immigration Reform.

21st Century Cures Initiative, drug pricing issues, the Promises for Antibiotics and Therapeutics for Health Act (S.185), proposals to create limited use pathways for certain drugs, CMS reimbursement.

Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.

Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.

Various patent litigation reforms that impact investment in the start-up ecosystem, including H.R. 9, S.1137, the TROL Act, and STRONG Patents Act.

Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration. EB-5 Visa, and Comprehensive Immigration Reform.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.

Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act, STRONG Patents Act.

21st Century Cures Initiative, drug pricing issues, S. 185 the Promises for Antibiotics and Therapeutics for Health Act and proposals to create limited use pathways for certain drugs, CMS reimbursement.

Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act, STRONG Patents Act.

Basic science research funding and tech transfer issues.

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Startup VISA Act; Invest VISA, Entrepreneurial VISA; Executive Order on Immigration. EB5 Visa.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.

Lobbied Congress on 21st Cures Initiative. Lobbied Congress on S.185 Promises for Antibiotics and Therapeutics for Health Act (PATH) Act, to create a limited population pathway for approval of certain antibacterial drugs. Worked with FDA on new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a limited use pathway which can be used for a broad set of diseases and legislation that would create new pathways for the payment of medical devices.

Basic science research funding.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.

Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act. STRONG Patents Act.

Basic science research funding.

House, draft bill 21st Cures Initiative, Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a limited use pathway which can be used for a broad set of diseases and legislation that would create new pathways for the payment of medical devices. S.185 Promises for Antibiotics and Therapeutics for Health Act (PATH) Act, to create a limited population pathway for approval of certain antibacterial drugs.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.

Small company capital formation issues, implementation of Dodd-Frank, Implementation of JOBS Act, Tick Size Pilot.

21st Century Cures Initiative, drug pricing issues, S. 185 the Promises for Antibiotics and Therapeutics for Health Act and proposals to create limited use pathways for certain drugs.

Startup VISA Act; Invest VISA, Entrepreneurial VISA; Executive Order on Immigration. EB5 Visa.

Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and RAISE Act.

Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act. STRONG Patents Act.

Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; Net Neutrality: Keep the internet free and open -- no "fast lanes".

Small company capital formation issues, implementation of Dodd-Frank, Implementation of JOBS Act, Tick Size Pilot.

Cleantech an Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act. STRONG Patents Act.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.

Small company capital formation issues, implementation of Dodd-Frank, Implementation of JOBS Act, Tick Size Pilot.

Cleantech an Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.

Startup VISA Act; Invest VISA, Entrepreneurial VISA; Executive Order on Immigration. EB5 Visa.

Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; Net Neutrality: Keep the internet free and open -- no "fast lanes".

Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.

Cleantech an Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations. Senate Finance Energy Tax Paper; RFI on American Innovation.

Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; Net Neutrality: Keep the internet free and open -- no "fast lanes".

Basic science research funding.

Small company capital formation issues, implementation of Dodd-Frank, Implementation of JOBS Act, Tick Size Pilot.

No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy ad Water Appropriations. Senate Finance Energy Tax Paper.

HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".

Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act.

HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.

S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.

No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill#: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin. and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill#: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).

Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act, Review of decimalization by the SEC, required under the JOBS Act. JOBS Act Roundtable.

HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy and Water Appropriations. Senate Finance Energy Tax Paper; RFI on American Innovation.

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).

S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.

HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".

HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.

No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy ad Water Appropriations. Senate Finance Energy Tax Paper.

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy and Water Appropriations. Senate Finance Energy Tax Paper

No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies for Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process.Requested Congress to have FDA review the SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics.

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)

HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations. Senate Finance Energy Tax Paper

S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013 Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft; Senate Finance tax discussion drafts.

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)

No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions No bill #: Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics. FDA Medical Mobile apps

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)

Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations. Senate Finance Energy Tax Paper

Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act

S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013

Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act

Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations.